Free Trial
NASDAQ:CRGX

CARGO Therapeutics (CRGX) Stock Price, News & Analysis

CARGO Therapeutics logo
$4.47 0.00 (0.00%)
As of 08/19/2025

About CARGO Therapeutics Stock (NASDAQ:CRGX)

Key Stats

Today's Range
$4.47
$4.47
50-Day Range
$4.12
$4.61
52-Week Range
$3.00
$25.45
Volume
N/A
Average Volume
1.73 million shs
Market Capitalization
$216.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.40
Consensus Rating
Reduce

Company Overview

CARGO Therapeutics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
41st Percentile Overall Score

CRGX MarketRank™: 

CARGO Therapeutics scored higher than 41% of companies evaluated by MarketBeat, and ranked 696th out of 949 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    CARGO Therapeutics has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    CARGO Therapeutics has only been the subject of 1 research reports in the past 90 days.

  • Read more about CARGO Therapeutics' stock forecast and price target.
  • Earnings Growth

    Earnings for CARGO Therapeutics are expected to grow in the coming year, from ($3.69) to ($2.27) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of CARGO Therapeutics is -0.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of CARGO Therapeutics is -0.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    CARGO Therapeutics has a P/B Ratio of 0.91. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about CARGO Therapeutics' valuation and earnings.
  • Short Interest

    There is no current short interest data available for CRGX.
  • Dividend Yield

    CARGO Therapeutics does not currently pay a dividend.

  • Dividend Growth

    CARGO Therapeutics does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for CRGX.
  • News Sentiment

    CARGO Therapeutics has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for CARGO Therapeutics this week, compared to 3 articles on an average week.
  • MarketBeat Follows

    2 people have added CARGO Therapeutics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, CARGO Therapeutics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.92% of the stock of CARGO Therapeutics is held by insiders.

  • Percentage Held by Institutions

    93.16% of the stock of CARGO Therapeutics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about CARGO Therapeutics' insider trading history.
Receive CRGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CARGO Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CRGX Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...tc pixel
CRGX - Cargo Therapeutics Inc Financials | Morningstar
See More Headlines

CRGX Stock Analysis - Frequently Asked Questions

CARGO Therapeutics' stock was trading at $14.42 at the beginning of 2025. Since then, CRGX shares have decreased by 69.0% and is now trading at $4.47.

CARGO Therapeutics, Inc. (NASDAQ:CRGX) posted its quarterly earnings data on Tuesday, November, 12th. The company reported ($0.88) EPS for the quarter, topping analysts' consensus estimates of ($1.14) by $0.26.

CARGO Therapeutics (CRGX) raised $281 million in an initial public offering (IPO) on Friday, November 10th 2023. The company issued 18,750,000 shares at $15.00 per share.

CARGO Therapeutics' top institutional investors include Geode Capital Management LLC (1.90%), Balyasny Asset Management L.P. (0.77%), JPMorgan Chase & Co. (0.43%) and BNP Paribas Financial Markets (0.28%). Insiders that own company stock include Samsara Biocapital Gp, Llc, Perceptive Advisors Llc, Gina Chapman and Anup Radhakrishnan.
View institutional ownership trends
.

Shares of CRGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CARGO Therapeutics investors own include Tesla (TSLA), Advanced Micro Devices (AMD), Meta Platforms (META), NVIDIA (NVDA), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Alphabet (GOOG).

Company Calendar

Last Earnings
11/12/2024
Today
8/28/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CRGX
Previous Symbol
NASDAQ:CRGX
CIK
1966494
Fax
N/A
Employees
116
Year Founded
N/A

Price Target and Rating

High Price Target
$33.00
Low Price Target
$4.00
Potential Upside/Downside
+244.5%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.64)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$167.50 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-43.21%
Return on Assets
-37.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.37
Quick Ratio
12.37

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.91 per share
Price / Book
0.91

Miscellaneous

Outstanding Shares
48,360,000
Free Float
46,952,000
Market Cap
$216.17 million
Optionable
N/A
Beta
0.30

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CRGX) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners